Article info
PDFOriginal Article
Pre-operative prediction of residual disease after interval cytoreduction for epithelial ovarian cancer using HE4
- Correspondence to Pien Lof, Department of Gynecology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands; p.lof{at}nki.nl
Citation
Pre-operative prediction of residual disease after interval cytoreduction for epithelial ovarian cancer using HE4
Publication history
- Received April 26, 2019
- Revision received July 15, 2019
- Accepted July 22, 2019
- First published September 11, 2019.
Article Versions
- You are currently viewing a Previous version of this article (30 September 2019).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ.